Stop guessing.
Start knowing.
You ask a client how they feel and get “six out of ten.” You can’t tell whether that’s the protocol working or a bad week. The CoreSignals Panel (CSP) from iXpressGenes replaces the guess with a signal you can re-measure after every intervention.
One panel. Six service lines you already sell.
CSP reports through six interpretive lenses, and each one maps to something already on your menu. Two read inflammation — one systemic, one in the joints. Two read the mind — one for state, one for depletion. Two read the body — one for metabolism, one for output. Same sample, same 22 signals, six different readings.
Lens
General Inflammation
Lens
Joint Inflammation
Lens
Mental Wellness
Lens
Burnout
Lens
Metabolic & Weight Loss
Lens
Athletic Performance
Everything on your menu is already chasing inflammation.
Chronic, low-grade inflammation is one of the recognized hallmarks of aging — and it’s what most of a longevity menu is already trying to move. What’s been missing is a way to show that it moved.
See the scienceDetect → Recommend → Verify.
A self-administered Tasso collection — no added headcount, on-site or at the client’s home. Results and trends flow into BioSignals Companion, the results app that carries your brand.
Detect
A baseline panel surfaces what's elevated — read across six interpretive lenses.
Recommend
Results return matched to a specific service from your own menu, backed by published research.
Verify
Retest after the intervention and confirm the signal actually moved.
Your brand, between visits.
Results deliver through BioSignals Companion, white-labeled to your practice. Your client opens an app that looks like you, watches their own signals move on retest, and comes back for the next one. Your brand stays in front of them between visits.
The Business Case
The retest cycle is already part of your model. CSP makes it measurable.
Built into a membership tier, used at intake, or held up as retention proof — and the logistics are simple: you ship the kit or collect on-site, iXG runs the lab and the report. The retest cycle is structural, not an upsell to invent.
See the partner case